Microbiology Research Group

Medicine & Life Sciences

1. Agar 8%
2. AIDS Vaccines 7%
3. Alphavirus 7%
4. Amoeba 6%
5. Anti-Infective Agents 35%
6. Antibodies 11%
7. Antibody Formation 6%
8. Antigens 13%
9. Antiviral Agents 10%
10. Bacillus 8%
11. Bangladesh 6%
12. bedaquiline 11%
13. Belgium 16%
14. Benin 10%
15. Benzophenoneidum 6%
16. Biomarkers 10%
17. Bovine Tuberculosis 9%
18. Buruli Ulcer 67%
19. Burundi 6%
20. Cambodia 6%
21. Cameroon 6%
22. Capreomycin 6%
23. CD4 Lymphocyte Count 14%
24. Cetylpyridinium 6%
25. Chikungunya virus 18%
26. Cohort Studies 6%
27. Coronavirus 6%
28. Cytokines 7%
29. Democratic Republic of the Congo 34%
30. Dendritic Cells 14%
31. Disease Outbreaks 13%
32. Drug Resistance 32%
33. Ebolavirus 6%
34. Ethiopia 11%
35. Extensively Drug-Resistant Tuberculosis 9%
36. Fluoroquinolones 10%
37. Gambia 6%
38. Genes 13%
39. Genome 20%
40. Genotype 15%
41. Ghana 6%
42. HIV 77%
43. HIV Infections 12%
44. HIV-1 69%
45. Human T-lymphotropic virus 1 9%
46. Immune Reconstitution Inflammatory Syndrome 22%
47. Immunoglobulin G 6%
48. Infection 18%
49. Isoniazid 22%
50. Kanamycin 8%
51. Lymph Node Tuberculosis 13%
52. Macaca 6%
53. Malaria 11%
54. Mali 10%
55. Messenger RNA 9%
56. Microbiota 11%
57. Microscopy 16%
58. Minisatellite Repeats 6%
59. Molecular Pathology 7%
60. Monocytes 10%
61. Multidrug-Resistant Tuberculosis 46%
62. Mutation 25%
63. Mycobacterium 42%
64. Mycobacterium bovis 12%
65. Mycobacterium tuberculosis 88%
66. Mycobacterium ulcerans 48%
67. Neutralizing Antibodies 14%
68. Niger 8%
69. Ofloxacin 9%
70. Peptides 6%
71. Peru 12%
72. Pharmaceutical Preparations 35%
73. Point-of-Care Systems 8%
74. Polymerase Chain Reaction 13%
75. Population 15%
76. Potassium Iodide 7%
77. Proteins 11%
78. Public Health 6%
79. Pulmonary Tuberculosis 11%
80. Pyrazinamide 8%
81. Recurrence 6%
82. Reverse Transcriptase Inhibitors 22%
83. Rifampin 49%
84. Routine Diagnostic Tests 11%
85. Safety 7%
86. Single Nucleotide Polymorphism 6%
87. Spinal Cord Diseases 6%
88. Sputum 28%
89. Streptomycin 8%
90. Syphilis 10%
91. T-Lymphocytes 31%
92. Therapeutics 24%
93. Tropical Spastic Paraparesis 10%
94. Tuberculosis 100%
95. Uganda 6%
96. Vaccination 9%
97. Vaccines 11%
98. Virus Diseases 9%
99. Viruses 25%
100. Western Africa 14%